Skip to main content
Search
Help

Oral Semaglutide

Oral Semaglutide is a separate oral-format listing. Absorption depends on the exact formulation.

Amount / form
What does the amount mean?

10 mg is an amount of material. Read the label to see whether it means per vial, per tablet, or per package.

Read more
Price not set

1 × selected package

This product is not available to order.

The research guide

Oral Semaglutide, explained

Oral Semaglutide is a separate oral-format listing. Absorption depends on the exact formulation.

What it’s used for

Oral Semaglutide is the separately listed oral-format concept for the GLP-1 receptor peptide, with research interest in peptide delivery, absorption and metabolic signaling.

Oral Semaglutide is the oral-format entry for semaglutide, a peptide that activates the GLP-1 receptor. This receptor is involved in glucose regulation and appetite signaling.

Oral-peptide research also examines the movement of a peptide across the digestive barrier, making formulation a central part of the research. Semaglutide's receptor activity and its delivery format are the two defining subjects for this entry.

Research interests
Weight loss · Appetite · Tablet format

Clinical oral-semaglutide results require the tested absorption formulation.

Side effects & safety

Clinical oral-semaglutide results require the tested absorption formulation.

Not rated

What the evidence covers

Exact product unrated; related tested oral formulation H4.

Exact formulation matters

Results from another route or a specially designed absorption formulation do not automatically apply to this oral product.

Sample testing and human safety

A sample's purity, content or endotoxin report answers a different question from clinical safety. It does not establish the safety or suitability of this product for a person.

Side effects

  • Common labelled events: The tablet label lists nausea, abdominal pain, diarrhea, reduced appetite, vomiting and constipation.

Stop and get help if

  • Important labelled risks: Warnings include pancreatitis, serious allergy, dehydration-associated kidney injury, gallbladder disease, severe gastrointestinal reactions and aspiration during anesthesia/deep sedation.
  • Thyroid findings: Human relevance of rodent thyroid C-cell tumors is unknown; MTC history and MEN2 are labelled contraindications.

How much people usually take

The labelled amount of Oral Semaglutide describes the listing quantity, not a personal dose.

Not rated. Clinical oral-semaglutide results require the tested absorption formulation. Trial amounts, schedules and monitoring belong to the specific study formulation and population; they cannot be converted into instructions for this listing.

A usual amount is not reported in the linked sources.

How to mix and store it

Oral Semaglutide is an oral format with its own formulation requirements.

An oral product cannot be evaluated by applying a vial's concentration calculation. Its finished formulation, ingredient quantities and absorption data must be considered separately.

Recorded presentation
Detailed presentation not supplied
Handling and formulationPreparation details
  1. Absorption formulation matters

    The two labelled tablet formulations are not interchangeable milligram for milligram. Their instructions cannot be transferred to an unspecified oral preparation.

Combining it with others

The cited research does not provide a verified combination guide for this Oral Semaglutide listing.

Results from another route or a specially designed absorption formulation do not automatically apply to this oral product. Catalogue categories and related-product cards are discovery tools; they do not establish compatibility, a stacking protocol or a tested combination.

What the research says

Not rated. Exact product unrated; related tested oral formulation H4.

These selected sources support the stated mechanism or research setting. They are not a systematic review, a test of Monroe inventory or an independent assessment of the finished product.

Semaglutide stomach absorption with SNAC

Primary work shows absorption required the studied SNAC coformulation; that composition is not established for Monroe's listing.

Semaglutide discovery and receptor activity

Primary chemistry supports compound-level GLP-1 analogue and receptor identity, not this oral formulation's performance.

How long it stays in your body

Half-life is the time it takes for the amount in the body to fall by half. It does not tell you how long effects last.

Half-life≈ 7 days
Mostly cleared35 daysAbout 97% gone after five half-lives
Half-lifeOral semaglutide co-formulated with SNAC
50%Estimated amount left
7 daysAfter one dose
Illustrative Oral Semaglutide half-life model: 50% remaining after 7 days. Normalized single exponential decline, not measured individual blood levels.0%50%100%0 d7 d14 d21 d28 d35 d

Drag to see how much is left over time.

What it’s made of

Molecular weight4113.58 g/mol
FormulaC187H291N45O59
Molecular notes

Semaglutide active molecule in the labelled SNAC tablets. The active-molecule formula does not describe the tablet’s excipients, absorption enhancer or release characteristics. Those are separate formulation questions.

Videos worth watching

Research conversations, with their original context.

Video resources are not available for this guide.

Read the original sources

Product details

Form
See the product label
Amount
Oral Semaglutide

Sources & further reading

Follow each reference to its original publication or documentation.

Questions

What does the labelled amount mean?

It describes an amount of material in the unit stated on the label. It does not describe liquid volume, a dose, or how to prepare the product.

Read more about amounts
How can I get help with an order?

Open your order details to check its current status. Shipping and support information are available below.

Contact us